AstraZeneca Pharma India Limited reported a 4.12% drop in net profit for the first quarter (Q1) of FY26 on last week. The company’s earnings dropped from Rs 58.2 crore in the previous quarter (Q4 FY25) to Rs 55.8 crore.

This decline occurred in spite of a robust increase in operating revenue, which increased 9.56 percent sequentially from Rs 480.4 crore to Rs 526.3 crore, as reported in its stock exchange filing.

Other income fell from Rs 16.1 crore in Q4 FY25 to Rs 11.2 crore, a steep loss of 30.43 percent.

Nonetheless, strong operational performance drove an 8.23% increase in total income from Rs 496.6 crore to Rs 537.5 crore.

According to the company’s regulatory filing, total expenses rose 12.12% to Rs 462.4 crore from Rs 412.4 crore in the prior quarter.

The company’s director and chief financial officer, Bhavana Agrawal, stated that the impressive quarterly results demonstrate the strength of rigorous execution coupled with science-led innovation.

“We are getting closer to improving outcomes for people with chronic illnesses with every regulatory milestone. We’re still committed to growing our business, fortifying alliances, and making sure that innovative medications get to the people who need them the most,” she continued.

Delivering steady growth across therapy areas, according to Praveen Rao Akkinepally, Country President and Managing Director, confirms the effectiveness of the business’s “Growth Through Innovation” approach.

“These outcomes demonstrate what can be achieved when science and purpose are combined,” he said.

The worldwide science-led biopharmaceutical business AstraZeneca is dedicated to the discovery, development, and commercialization of prescription medications, mainly in the areas of rare diseases, cardiovascular, respiratory, renal, and metabolic, as well as oncology.

Millions of patients utilize the company’s medications worldwide, and it operates in more than 100 countries.

AstraZeneca Pharma India Limited, which has been in India for 45 years, has more than 600 employees nationwide and its headquarters are in Bengaluru.